

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of cholesterol esterification (GO:0010872) | 6.68116273 |
| 2 | plasma lipoprotein particle assembly (GO:0034377) | 6.20611391 |
| 3 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.14293652 |
| 4 | protein-lipid complex remodeling (GO:0034368) | 5.75311029 |
| 5 | macromolecular complex remodeling (GO:0034367) | 5.75311029 |
| 6 | plasma lipoprotein particle remodeling (GO:0034369) | 5.75311029 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.68551944 |
| 8 | high-density lipoprotein particle remodeling (GO:0034375) | 5.67605550 |
| 9 | protein-lipid complex assembly (GO:0065005) | 5.66166902 |
| 10 | negative regulation of fibrinolysis (GO:0051918) | 5.54512943 |
| 11 | low-density lipoprotein particle remodeling (GO:0034374) | 5.47158542 |
| 12 | phospholipid efflux (GO:0033700) | 5.42181708 |
| 13 | cholesterol efflux (GO:0033344) | 5.35278919 |
| 14 | negative regulation of cholesterol transport (GO:0032375) | 5.25418976 |
| 15 | negative regulation of sterol transport (GO:0032372) | 5.25418976 |
| 16 | protein carboxylation (GO:0018214) | 5.20718355 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.20718355 |
| 18 | reverse cholesterol transport (GO:0043691) | 5.19300909 |
| 19 | plasma lipoprotein particle organization (GO:0071827) | 4.92558733 |
| 20 | regulation of fibrinolysis (GO:0051917) | 4.91744898 |
| 21 | plasma lipoprotein particle clearance (GO:0034381) | 4.90811408 |
| 22 | protein-lipid complex subunit organization (GO:0071825) | 4.70622506 |
| 23 | regulation of bile acid biosynthetic process (GO:0070857) | 4.63830130 |
| 24 | regulation of cholesterol homeostasis (GO:2000188) | 4.40344983 |
| 25 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.38270908 |
| 26 | regulation of plasminogen activation (GO:0010755) | 4.32906961 |
| 27 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.32666912 |
| 28 | intestinal cholesterol absorption (GO:0030299) | 4.24684251 |
| 29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.07093233 |
| 30 | L-phenylalanine catabolic process (GO:0006559) | 4.07093233 |
| 31 | proline metabolic process (GO:0006560) | 4.05860371 |
| 32 | central nervous system myelination (GO:0022010) | 4.05101531 |
| 33 | axon ensheathment in central nervous system (GO:0032291) | 4.05101531 |
| 34 | L-phenylalanine metabolic process (GO:0006558) | 4.04191640 |
| 35 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.04191640 |
| 36 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.04177810 |
| 37 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.04151480 |
| 38 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.04151480 |
| 39 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.01738001 |
| 40 | lung epithelium development (GO:0060428) | 3.99182401 |
| 41 | regulation of protein activation cascade (GO:2000257) | 3.95508399 |
| 42 | regulation of complement activation (GO:0030449) | 3.88792357 |
| 43 | positive regulation of steroid metabolic process (GO:0045940) | 3.87146096 |
| 44 | regulation of apoptotic cell clearance (GO:2000425) | 3.81197096 |
| 45 | negative regulation of lipase activity (GO:0060192) | 3.74473482 |
| 46 | glutamate metabolic process (GO:0006536) | 3.60351257 |
| 47 | cellular sodium ion homeostasis (GO:0006883) | 3.54842809 |
| 48 | regulation of cholesterol metabolic process (GO:0090181) | 3.43764495 |
| 49 | diacylglycerol metabolic process (GO:0046339) | 3.42139630 |
| 50 | positive regulation of synapse maturation (GO:0090129) | 3.42110463 |
| 51 | acylglycerol homeostasis (GO:0055090) | 3.40126400 |
| 52 | triglyceride homeostasis (GO:0070328) | 3.40126400 |
| 53 | lipoprotein metabolic process (GO:0042157) | 3.37593414 |
| 54 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.34524415 |
| 55 | blood coagulation, intrinsic pathway (GO:0007597) | 3.23802865 |
| 56 | fibrinolysis (GO:0042730) | 3.23603220 |
| 57 | intestinal absorption (GO:0050892) | 3.20577695 |
| 58 | positive regulation of dendritic spine development (GO:0060999) | 3.18876418 |
| 59 | negative regulation of blood coagulation (GO:0030195) | 3.17379006 |
| 60 | negative regulation of hemostasis (GO:1900047) | 3.17379006 |
| 61 | regulation of extracellular matrix disassembly (GO:0010715) | 3.15448213 |
| 62 | sterol transport (GO:0015918) | 3.15409097 |
| 63 | cholesterol transport (GO:0030301) | 3.15409097 |
| 64 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.14778450 |
| 65 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.10470953 |
| 66 | negative regulation of lipid transport (GO:0032369) | 3.08982317 |
| 67 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.08537450 |
| 68 | cholesterol homeostasis (GO:0042632) | 3.07002232 |
| 69 | regulation of extracellular matrix organization (GO:1903053) | 3.06485003 |
| 70 | positive regulation of extracellular matrix organization (GO:1903055) | 3.01240944 |
| 71 | glutamate secretion (GO:0014047) | 3.01197094 |
| 72 | sterol homeostasis (GO:0055092) | 3.00905138 |
| 73 | negative regulation of sodium ion transport (GO:0010766) | 2.94035150 |
| 74 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.92536070 |
| 75 | regulation of lipoprotein particle clearance (GO:0010984) | 2.91145559 |
| 76 | sodium ion export (GO:0071436) | 2.90015713 |
| 77 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.88512618 |
| 78 | complement activation, alternative pathway (GO:0006957) | 2.88340358 |
| 79 | synaptic vesicle exocytosis (GO:0016079) | 2.87244662 |
| 80 | cellular potassium ion homeostasis (GO:0030007) | 2.87014164 |
| 81 | regulation of synapse maturation (GO:0090128) | 2.86986702 |
| 82 | negative regulation of coagulation (GO:0050819) | 2.85662521 |
| 83 | sodium ion homeostasis (GO:0055078) | 2.84203830 |
| 84 | C4-dicarboxylate transport (GO:0015740) | 2.83287348 |
| 85 | vitamin transmembrane transport (GO:0035461) | 2.82355344 |
| 86 | positive regulation of lipid catabolic process (GO:0050996) | 2.82044784 |
| 87 | vocalization behavior (GO:0071625) | 2.81201034 |
| 88 | cellular zinc ion homeostasis (GO:0006882) | 2.78298118 |
| 89 | cell-cell junction maintenance (GO:0045217) | 2.77720491 |
| 90 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.76331336 |
| 91 | drinking behavior (GO:0042756) | 2.72694701 |
| 92 | proline biosynthetic process (GO:0006561) | 2.72373158 |
| 93 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.71091077 |
| 94 | acute-phase response (GO:0006953) | 2.69433057 |
| 95 | short-term memory (GO:0007614) | 2.66830568 |
| 96 | negative regulation of wound healing (GO:0061045) | 2.65624198 |
| 97 | layer formation in cerebral cortex (GO:0021819) | 2.64958726 |
| 98 | artery smooth muscle contraction (GO:0014824) | 2.64293334 |
| 99 | amino acid import (GO:0043090) | 2.61644892 |
| 100 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.59326065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.32016786 |
| 2 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.73007675 |
| 3 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.26114018 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.11024342 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.80519707 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.55188694 |
| 7 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.53914955 |
| 8 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.51897241 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.40027847 |
| 10 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.35922495 |
| 11 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.35744395 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.32219725 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.16931403 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.16193530 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.10030032 |
| 16 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.01839754 |
| 17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.95967563 |
| 18 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.94879870 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.87710658 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.85146078 |
| 21 | KDM2B_26808549_Chip-Seq_K562_Human | 1.81609488 |
| 22 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.78821091 |
| 23 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.78011698 |
| 24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.77575617 |
| 25 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.77417619 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76250534 |
| 27 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.74320587 |
| 28 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.73911201 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.69729467 |
| 30 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.69470598 |
| 31 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.66431155 |
| 32 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.64158373 |
| 33 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.62950652 |
| 34 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.61233759 |
| 35 | P68_20966046_ChIP-Seq_HELA_Human | 1.61210388 |
| 36 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.60292838 |
| 37 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.59357284 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.55560673 |
| 39 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.53154623 |
| 40 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.48498713 |
| 41 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.48129432 |
| 42 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.48129432 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.45527171 |
| 44 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.42857797 |
| 45 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.41789817 |
| 46 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.40847325 |
| 47 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.40278045 |
| 48 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.39782212 |
| 49 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.39170514 |
| 50 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.37731962 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37434448 |
| 52 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.33358015 |
| 53 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31976774 |
| 54 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.31328114 |
| 55 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.30675070 |
| 56 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.25952726 |
| 57 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.25538167 |
| 58 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.24531138 |
| 59 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.21077165 |
| 60 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.19292348 |
| 61 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.17757677 |
| 62 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.16869047 |
| 63 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.16545883 |
| 64 | SA1_27219007_Chip-Seq_Bcells_Human | 1.16018148 |
| 65 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.15954841 |
| 66 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.15750787 |
| 67 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.14013820 |
| 68 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12658789 |
| 69 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.12647185 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.12604492 |
| 71 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.11700634 |
| 72 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.10958252 |
| 73 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10030496 |
| 74 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.09073593 |
| 75 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.08555828 |
| 76 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.08532315 |
| 77 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.08275488 |
| 78 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07807893 |
| 79 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.07393125 |
| 80 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.06608766 |
| 81 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.05898581 |
| 82 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03886486 |
| 83 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.03380780 |
| 84 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03270036 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02638558 |
| 86 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.00822457 |
| 87 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.00769946 |
| 88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00611637 |
| 89 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00325625 |
| 90 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.00281875 |
| 91 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.00248608 |
| 92 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99186322 |
| 93 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.98068022 |
| 94 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.98016923 |
| 95 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.97482466 |
| 96 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.96826268 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96816095 |
| 98 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.95771468 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94138140 |
| 100 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.92719526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.72744559 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.96052580 |
| 3 | MP0005365_abnormal_bile_salt | 4.32360040 |
| 4 | MP0000566_synostosis | 3.78455677 |
| 5 | MP0003122_maternal_imprinting | 3.58755195 |
| 6 | MP0003195_calcinosis | 3.17470674 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.12806873 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 2.90371206 |
| 9 | MP0009840_abnormal_foam_cell | 2.79929912 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.76126105 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.54490849 |
| 12 | MP0004270_analgesia | 2.54311689 |
| 13 | MP0003879_abnormal_hair_cell | 2.48305102 |
| 14 | MP0009780_abnormal_chondrocyte_physiolo | 2.45212611 |
| 15 | MP0003329_amyloid_beta_deposits | 2.44047381 |
| 16 | MP0003123_paternal_imprinting | 2.33985381 |
| 17 | MP0002089_abnormal_postnatal_growth/wei | 2.27475843 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.26621466 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.21945295 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 2.13339794 |
| 21 | MP0002064_seizures | 2.10722097 |
| 22 | MP0003880_abnormal_central_pattern | 1.97383813 |
| 23 | MP0003635_abnormal_synaptic_transmissio | 1.87924295 |
| 24 | MP0003868_abnormal_feces_composition | 1.84843979 |
| 25 | MP0005167_abnormal_blood-brain_barrier | 1.79227995 |
| 26 | MP0005646_abnormal_pituitary_gland | 1.73100218 |
| 27 | MP0000920_abnormal_myelination | 1.66419796 |
| 28 | MP0001486_abnormal_startle_reflex | 1.66172419 |
| 29 | MP0000604_amyloidosis | 1.60723210 |
| 30 | MP0005409_darkened_coat_color | 1.59646346 |
| 31 | MP0003690_abnormal_glial_cell | 1.57015576 |
| 32 | MP0002063_abnormal_learning/memory/cond | 1.54432311 |
| 33 | MP0005332_abnormal_amino_acid | 1.42808788 |
| 34 | MP0005451_abnormal_body_composition | 1.41102202 |
| 35 | MP0002572_abnormal_emotion/affect_behav | 1.40076991 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.39962716 |
| 37 | MP0003252_abnormal_bile_duct | 1.38040615 |
| 38 | MP0002272_abnormal_nervous_system | 1.37535579 |
| 39 | MP0009745_abnormal_behavioral_response | 1.30883041 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.30217554 |
| 41 | MP0002734_abnormal_mechanical_nocicepti | 1.30111029 |
| 42 | MP0004264_abnormal_extraembryonic_tissu | 1.29313388 |
| 43 | MP0008569_lethality_at_weaning | 1.23638577 |
| 44 | MP0002735_abnormal_chemical_nociception | 1.22876213 |
| 45 | MP0003633_abnormal_nervous_system | 1.22092590 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.18456804 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.16942799 |
| 48 | MP0000609_abnormal_liver_physiology | 1.09326127 |
| 49 | MP0003631_nervous_system_phenotype | 1.08636920 |
| 50 | MP0004019_abnormal_vitamin_homeostasis | 1.08380134 |
| 51 | MP0009046_muscle_twitch | 1.06940145 |
| 52 | MP0005377_hearing/vestibular/ear_phenot | 1.05299381 |
| 53 | MP0003878_abnormal_ear_physiology | 1.05299381 |
| 54 | MP0003632_abnormal_nervous_system | 1.04505118 |
| 55 | MP0000639_abnormal_adrenal_gland | 1.02242301 |
| 56 | MP0001501_abnormal_sleep_pattern | 0.99761928 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 0.98311407 |
| 58 | MP0002557_abnormal_social/conspecific_i | 0.96613074 |
| 59 | MP0004742_abnormal_vestibular_system | 0.94647628 |
| 60 | MP0003634_abnormal_glial_cell | 0.93568066 |
| 61 | MP0001970_abnormal_pain_threshold | 0.92550906 |
| 62 | MP0004885_abnormal_endolymph | 0.92314433 |
| 63 | MP0005670_abnormal_white_adipose | 0.91451539 |
| 64 | MP0001984_abnormal_olfaction | 0.91297986 |
| 65 | MP0002733_abnormal_thermal_nociception | 0.89753183 |
| 66 | MP0000003_abnormal_adipose_tissue | 0.88747176 |
| 67 | MP0005448_abnormal_energy_balance | 0.85007807 |
| 68 | MP0001968_abnormal_touch/_nociception | 0.83994251 |
| 69 | MP0003075_altered_response_to | 0.82996456 |
| 70 | MP0002249_abnormal_larynx_morphology | 0.82123724 |
| 71 | MP0003183_abnormal_peptide_metabolism | 0.76125229 |
| 72 | MP0005636_abnormal_mineral_homeostasis | 0.75978877 |
| 73 | MP0002971_abnormal_brown_adipose | 0.75515700 |
| 74 | MP0002066_abnormal_motor_capabilities/c | 0.75379790 |
| 75 | MP0005084_abnormal_gallbladder_morpholo | 0.74414678 |
| 76 | MP0001502_abnormal_circadian_rhythm | 0.73526372 |
| 77 | MP0002067_abnormal_sensory_capabilities | 0.73211485 |
| 78 | MP0002229_neurodegeneration | 0.72712883 |
| 79 | MP0001915_intracranial_hemorrhage | 0.72109812 |
| 80 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70481766 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 0.70077579 |
| 82 | MP0000955_abnormal_spinal_cord | 0.69782327 |
| 83 | MP0005551_abnormal_eye_electrophysiolog | 0.67965860 |
| 84 | MP0002882_abnormal_neuron_morphology | 0.66447630 |
| 85 | MP0002078_abnormal_glucose_homeostasis | 0.66344539 |
| 86 | MP0009643_abnormal_urine_homeostasis | 0.65248841 |
| 87 | MP0001765_abnormal_ion_homeostasis | 0.64405475 |
| 88 | MP0003953_abnormal_hormone_level | 0.62315667 |
| 89 | MP0001346_abnormal_lacrimal_gland | 0.60972941 |
| 90 | MP0001756_abnormal_urination | 0.59848913 |
| 91 | MP0009642_abnormal_blood_homeostasis | 0.58080007 |
| 92 | MP0003115_abnormal_respiratory_system | 0.57989981 |
| 93 | MP0005379_endocrine/exocrine_gland_phen | 0.57098768 |
| 94 | MP0004811_abnormal_neuron_physiology | 0.56617212 |
| 95 | MP0004130_abnormal_muscle_cell | 0.56341887 |
| 96 | MP0001299_abnormal_eye_distance/ | 0.55228366 |
| 97 | MP0001963_abnormal_hearing_physiology | 0.54935965 |
| 98 | MP0002822_catalepsy | 0.54737533 |
| 99 | MP0009115_abnormal_fat_cell | 0.54268684 |
| 100 | MP0001764_abnormal_homeostasis | 0.53553894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 8.53147668 |
| 2 | Joint hemorrhage (HP:0005261) | 5.34286910 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 5.04756380 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 4.96938534 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.76385871 |
| 6 | Xanthomatosis (HP:0000991) | 4.64639477 |
| 7 | Hemorrhage of the eye (HP:0011885) | 4.56654357 |
| 8 | Complement deficiency (HP:0004431) | 4.05141168 |
| 9 | Hypercholesterolemia (HP:0003124) | 3.71318218 |
| 10 | Alacrima (HP:0000522) | 3.65850511 |
| 11 | Neurofibrillary tangles (HP:0002185) | 3.55412495 |
| 12 | Menstrual irregularities (HP:0000858) | 3.53405738 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.47929402 |
| 14 | Glomerulonephritis (HP:0000099) | 3.45211691 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 3.34950903 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.33966475 |
| 17 | Abnormality of carpal bone ossification (HP:0006257) | 3.31987958 |
| 18 | Flat acetabular roof (HP:0003180) | 3.30836922 |
| 19 | Myokymia (HP:0002411) | 3.18519101 |
| 20 | Obstructive sleep apnea (HP:0002870) | 3.15473743 |
| 21 | Abnormality of complement system (HP:0005339) | 3.02300572 |
| 22 | Stridor (HP:0010307) | 2.94211711 |
| 23 | Growth hormone excess (HP:0000845) | 2.82203081 |
| 24 | Distal upper limb amyotrophy (HP:0007149) | 2.80054928 |
| 25 | Upper limb amyotrophy (HP:0009129) | 2.80054928 |
| 26 | Action tremor (HP:0002345) | 2.78754211 |
| 27 | Bronchomalacia (HP:0002780) | 2.77050828 |
| 28 | Cerebral inclusion bodies (HP:0100314) | 2.75461602 |
| 29 | Hand muscle atrophy (HP:0009130) | 2.74957868 |
| 30 | Mitral stenosis (HP:0001718) | 2.74940954 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 2.70659778 |
| 32 | Abnormal ossification of hand bones (HP:0005921) | 2.64983561 |
| 33 | Menorrhagia (HP:0000132) | 2.63074891 |
| 34 | Abnormal hand bone ossification (HP:0010660) | 2.57637485 |
| 35 | Asymmetry of the thorax (HP:0001555) | 2.57171130 |
| 36 | Decreased lacrimation (HP:0000633) | 2.52934560 |
| 37 | Epiphyseal dysplasia (HP:0002656) | 2.52205255 |
| 38 | Vascular calcification (HP:0004934) | 2.51231859 |
| 39 | Abnormality of the common coagulation pathway (HP:0010990) | 2.43605366 |
| 40 | Late onset (HP:0003584) | 2.37753807 |
| 41 | Focal motor seizures (HP:0011153) | 2.33805256 |
| 42 | Hyperglycinemia (HP:0002154) | 2.31029396 |
| 43 | Purpura (HP:0000979) | 2.30069433 |
| 44 | Supranuclear gaze palsy (HP:0000605) | 2.29600321 |
| 45 | Diaphragmatic weakness (HP:0009113) | 2.29239805 |
| 46 | Hyperlipoproteinemia (HP:0010980) | 2.28748467 |
| 47 | Epileptic encephalopathy (HP:0200134) | 2.28612864 |
| 48 | Spontaneous abortion (HP:0005268) | 2.27295873 |
| 49 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.24980749 |
| 50 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.24655018 |
| 51 | Aplasia of the phalanges of the hand (HP:0009802) | 2.24655018 |
| 52 | Aplasia involving bones of the extremities (HP:0009825) | 2.24655018 |
| 53 | Ankle clonus (HP:0011448) | 2.24058627 |
| 54 | Delayed CNS myelination (HP:0002188) | 2.19949316 |
| 55 | Facial shape deformation (HP:0011334) | 2.18829925 |
| 56 | Potter facies (HP:0002009) | 2.18829925 |
| 57 | Akinesia (HP:0002304) | 2.15352991 |
| 58 | Abnormality of binocular vision (HP:0011514) | 2.11693490 |
| 59 | Diplopia (HP:0000651) | 2.11693490 |
| 60 | Impaired pain sensation (HP:0007328) | 2.10852751 |
| 61 | Abnormality of pain sensation (HP:0010832) | 2.10852751 |
| 62 | Hypophosphatemic rickets (HP:0004912) | 2.10507916 |
| 63 | Focal seizures (HP:0007359) | 2.08861952 |
| 64 | Partial duplication of thumb phalanx (HP:0009944) | 2.08724157 |
| 65 | Epidermoid cyst (HP:0200040) | 2.07558869 |
| 66 | Acanthocytosis (HP:0001927) | 2.07115060 |
| 67 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.06291207 |
| 68 | Cardiovascular calcification (HP:0011915) | 2.05590033 |
| 69 | Bifid scrotum (HP:0000048) | 2.02586652 |
| 70 | Abnormal tarsal ossification (HP:0008369) | 2.01988776 |
| 71 | Neonatal death (HP:0003811) | 2.01776378 |
| 72 | Torticollis (HP:0000473) | 2.00681969 |
| 73 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.97613016 |
| 74 | Sleep apnea (HP:0010535) | 1.94234951 |
| 75 | Abnormality of the musculature of the hand (HP:0001421) | 1.93341057 |
| 76 | Small epiphyses (HP:0010585) | 1.92905140 |
| 77 | Conjugated hyperbilirubinemia (HP:0002908) | 1.88032384 |
| 78 | Intrahepatic cholestasis (HP:0001406) | 1.87721533 |
| 79 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.85923364 |
| 80 | Abnormality of glycine metabolism (HP:0010895) | 1.85923364 |
| 81 | Focal dystonia (HP:0004373) | 1.85844769 |
| 82 | Hydroxyprolinuria (HP:0003080) | 1.84878771 |
| 83 | Abnormality of proline metabolism (HP:0010907) | 1.84878771 |
| 84 | Neonatal short-limb short stature (HP:0008921) | 1.84216174 |
| 85 | Abnormality of the Achilles tendon (HP:0005109) | 1.83872321 |
| 86 | Amyloidosis (HP:0011034) | 1.83748607 |
| 87 | Confusion (HP:0001289) | 1.83156778 |
| 88 | Status epilepticus (HP:0002133) | 1.82202720 |
| 89 | Spinal cord compression (HP:0002176) | 1.81970538 |
| 90 | Megalencephaly (HP:0001355) | 1.81753049 |
| 91 | Craniofacial dystonia (HP:0012179) | 1.81706317 |
| 92 | Short femoral neck (HP:0100864) | 1.77037003 |
| 93 | Widely patent fontanelles and sutures (HP:0004492) | 1.77032033 |
| 94 | Dysmetria (HP:0001310) | 1.76980729 |
| 95 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.76546378 |
| 96 | Paraparesis (HP:0002385) | 1.76210889 |
| 97 | Fat malabsorption (HP:0002630) | 1.71661929 |
| 98 | Rickets (HP:0002748) | 1.71525356 |
| 99 | Nephritis (HP:0000123) | 1.70862880 |
| 100 | Lower limb asymmetry (HP:0100559) | 1.68475116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 5.65021926 |
| 2 | EPHA4 | 3.93696517 |
| 3 | ICK | 3.06693203 |
| 4 | TRIB3 | 3.00623065 |
| 5 | NTRK3 | 2.91689380 |
| 6 | TYRO3 | 2.91668554 |
| 7 | RIPK1 | 2.91098276 |
| 8 | CAMKK1 | 2.63701385 |
| 9 | FGFR3 | 2.46335763 |
| 10 | ERN1 | 2.36253044 |
| 11 | CAMKK2 | 2.25088090 |
| 12 | SIK2 | 2.04783488 |
| 13 | PRKD3 | 1.98135684 |
| 14 | FGFR2 | 1.87933858 |
| 15 | SIK1 | 1.84314524 |
| 16 | DAPK2 | 1.72435972 |
| 17 | WNK4 | 1.64721574 |
| 18 | CDK12 | 1.59209781 |
| 19 | MAP3K11 | 1.54558406 |
| 20 | DDR2 | 1.46111636 |
| 21 | PDGFRA | 1.45898913 |
| 22 | PAK6 | 1.41892609 |
| 23 | PKN2 | 1.37722213 |
| 24 | LMTK2 | 1.37029801 |
| 25 | NTRK2 | 1.36462676 |
| 26 | EPHA2 | 1.34065130 |
| 27 | NTRK1 | 1.31278478 |
| 28 | MARK1 | 1.29227473 |
| 29 | UHMK1 | 1.28804260 |
| 30 | TNK2 | 1.26277073 |
| 31 | MARK2 | 1.26085550 |
| 32 | PIK3CA | 1.24634723 |
| 33 | DYRK1B | 1.19272851 |
| 34 | SGK223 | 1.17776680 |
| 35 | SGK494 | 1.17776680 |
| 36 | CDC42BPA | 1.16588144 |
| 37 | MINK1 | 1.15466979 |
| 38 | RET | 1.07646674 |
| 39 | PDPK1 | 1.06281745 |
| 40 | CAMK1D | 1.04802337 |
| 41 | SGK1 | 1.00649741 |
| 42 | PRKCG | 1.00261992 |
| 43 | CAMK4 | 0.99525082 |
| 44 | MST1R | 0.94673850 |
| 45 | PTK6 | 0.94007488 |
| 46 | ALK | 0.92796995 |
| 47 | FGFR1 | 0.87977475 |
| 48 | CAMK1 | 0.86406164 |
| 49 | BMX | 0.86003671 |
| 50 | CASK | 0.84899348 |
| 51 | ERBB2 | 0.80906933 |
| 52 | CDK5 | 0.80451980 |
| 53 | MAPK11 | 0.79215431 |
| 54 | MAP3K1 | 0.77926298 |
| 55 | PHKG2 | 0.77212670 |
| 56 | PHKG1 | 0.77212670 |
| 57 | PRKG2 | 0.76841961 |
| 58 | PRKCZ | 0.75134432 |
| 59 | MET | 0.75014866 |
| 60 | PDK1 | 0.74617899 |
| 61 | SGK3 | 0.74017374 |
| 62 | MAPK13 | 0.71899711 |
| 63 | KSR2 | 0.67820982 |
| 64 | EEF2K | 0.64878544 |
| 65 | MAP2K6 | 0.64708014 |
| 66 | SGK2 | 0.62670769 |
| 67 | DAPK1 | 0.62663371 |
| 68 | CAMK2B | 0.62441305 |
| 69 | IRAK3 | 0.61702692 |
| 70 | EPHB1 | 0.61355045 |
| 71 | WNK1 | 0.61231060 |
| 72 | PRKAA2 | 0.60017848 |
| 73 | MAP3K7 | 0.57558665 |
| 74 | CAMK1G | 0.56381339 |
| 75 | STK38 | 0.55344834 |
| 76 | TAOK1 | 0.54690996 |
| 77 | CDK15 | 0.54427473 |
| 78 | GRK5 | 0.53195934 |
| 79 | SMG1 | 0.52925264 |
| 80 | CAMK2G | 0.52452473 |
| 81 | PTK2 | 0.50113849 |
| 82 | RPS6KA3 | 0.50087210 |
| 83 | CDK11A | 0.50017017 |
| 84 | CSNK1E | 0.49513086 |
| 85 | MAPK10 | 0.49439052 |
| 86 | BRSK1 | 0.49299512 |
| 87 | CDK18 | 0.48167135 |
| 88 | PRKAA1 | 0.45852270 |
| 89 | PRKD2 | 0.45264161 |
| 90 | MAP3K2 | 0.45173550 |
| 91 | CAMK2A | 0.44883299 |
| 92 | PRPF4B | 0.44754962 |
| 93 | SRC | 0.43125930 |
| 94 | LATS2 | 0.42594819 |
| 95 | CAMK2D | 0.40298004 |
| 96 | CDK14 | 0.39747136 |
| 97 | PRKCH | 0.37553703 |
| 98 | PRKACG | 0.37343504 |
| 99 | MAPK8 | 0.37084485 |
| 100 | MTOR | 0.32557771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.59374414 |
| 2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.44067555 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.93962443 |
| 4 | Histidine metabolism_Homo sapiens_hsa00340 | 2.71164443 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.62364335 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48006510 |
| 7 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.23322258 |
| 8 | Bile secretion_Homo sapiens_hsa04976 | 2.17250814 |
| 9 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 2.09098939 |
| 10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.05389828 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.02442657 |
| 12 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.95965910 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.84892668 |
| 14 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.84037811 |
| 15 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.82110160 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.72162268 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.71728857 |
| 18 | Sulfur relay system_Homo sapiens_hsa04122 | 1.71005005 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.57646184 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.57037690 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.42516453 |
| 22 | Nicotine addiction_Homo sapiens_hsa05033 | 1.34943487 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.32904090 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.31673690 |
| 25 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.28056934 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.23661463 |
| 27 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.23384892 |
| 28 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.21257315 |
| 29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.19825328 |
| 30 | Long-term potentiation_Homo sapiens_hsa04720 | 1.18515408 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.17422801 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.14331718 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.13458241 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10664055 |
| 35 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.09107960 |
| 36 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.03442222 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02974823 |
| 38 | Mineral absorption_Homo sapiens_hsa04978 | 1.02831737 |
| 39 | Insulin secretion_Homo sapiens_hsa04911 | 1.02696217 |
| 40 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.02237287 |
| 41 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.01587503 |
| 42 | GABAergic synapse_Homo sapiens_hsa04727 | 1.00553276 |
| 43 | Prion diseases_Homo sapiens_hsa05020 | 0.99291040 |
| 44 | Lysine degradation_Homo sapiens_hsa00310 | 0.98251502 |
| 45 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.97528707 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.96039888 |
| 47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94178771 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.91122759 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85432787 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.85129904 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.84967970 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82002905 |
| 53 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.81931590 |
| 54 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.81154957 |
| 55 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.78706989 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76207443 |
| 57 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.75822162 |
| 58 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73049558 |
| 59 | Cocaine addiction_Homo sapiens_hsa05030 | 0.71573548 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69898864 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68914501 |
| 62 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.67516355 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.66630341 |
| 64 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66549082 |
| 65 | Circadian entrainment_Homo sapiens_hsa04713 | 0.66237723 |
| 66 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.64247179 |
| 67 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63820344 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.62859266 |
| 69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61938869 |
| 70 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61508317 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58174904 |
| 72 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.57932527 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.56424618 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.54760293 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54132899 |
| 76 | Morphine addiction_Homo sapiens_hsa05032 | 0.53707770 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.52678036 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52418845 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48107875 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46652762 |
| 81 | Salivary secretion_Homo sapiens_hsa04970 | 0.46573799 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46319497 |
| 83 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45953744 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44811226 |
| 85 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.44286960 |
| 86 | Axon guidance_Homo sapiens_hsa04360 | 0.43075900 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43014918 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42564116 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.42416085 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41329689 |
| 91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39284809 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38252016 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.37993068 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.37907063 |
| 95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37737082 |
| 96 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37529037 |
| 97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36588651 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36089787 |
| 99 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.35977257 |
| 100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.35490647 |

